ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $199,000 | -31.1% | 54,300 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $289,000 | +37.0% | 108,600 | +63.8% | 0.00% | 0.0% |
| Q1 2019 | $211,000 | +174.0% | 66,300 | +22.1% | 0.00% | 0.0% |
| Q4 2018 | $77,000 | -63.5% | 54,300 | -18.1% | 0.00% | 0.0% |
| Q3 2018 | $211,000 | +8.2% | 66,300 | -2.9% | 0.00% | 0.0% |
| Q2 2018 | $195,000 | -22.9% | 68,300 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $253,000 | -25.8% | 68,300 | -2.1% | 0.00% | -33.3% |
| Q4 2017 | $341,000 | 0.0% | 69,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $341,000 | +8.6% | 69,800 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $314,000 | +5.0% | 69,800 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $299,000 | -3.2% | 69,800 | -7.9% | 0.00% | 0.0% |
| Q4 2016 | $309,000 | -44.5% | 75,800 | +7.8% | 0.00% | -50.0% |
| Q3 2016 | $557,000 | +1.1% | 70,300 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $551,000 | +24.9% | 70,300 | +20.0% | 0.01% | +20.0% |
| Q1 2016 | $441,000 | -41.1% | 58,600 | -15.8% | 0.01% | -44.4% |
| Q4 2015 | $749,000 | +58.0% | 69,600 | +1.5% | 0.01% | +50.0% |
| Q3 2015 | $474,000 | -3.9% | 68,600 | +23.4% | 0.01% | 0.0% |
| Q2 2015 | $493,000 | -6.6% | 55,600 | +3.7% | 0.01% | -14.3% |
| Q1 2015 | $528,000 | -18.0% | 53,600 | +2.3% | 0.01% | -12.5% |
| Q4 2014 | $644,000 | +13.2% | 52,400 | -8.1% | 0.01% | 0.0% |
| Q3 2014 | $569,000 | -76.9% | 57,000 | -82.5% | 0.01% | -78.4% |
| Q2 2014 | $2,464,000 | +1157.1% | 325,500 | +447.1% | 0.04% | +1133.3% |
| Q1 2014 | $196,000 | +9.5% | 59,500 | +8.2% | 0.00% | 0.0% |
| Q4 2013 | $179,000 | +9.8% | 55,000 | +1.9% | 0.00% | 0.0% |
| Q3 2013 | $163,000 | -62.4% | 54,000 | +2.9% | 0.00% | -62.5% |
| Q2 2013 | $433,000 | – | 52,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |